147 related articles for article (PubMed ID: 12403908)
1. Effect of ethanol on antigenicity of hepatitis B virus envelope proteins.
Ito K; Kajiura T; Abe K
Jpn J Infect Dis; 2002 Aug; 55(4):117-21. PubMed ID: 12403908
[TBL] [Abstract][Full Text] [Related]
2. Pre-S proteins in chronic hepatitis B virus infection: markers of active viral infection.
Kakumu S; Arao M; Mizokami M; Orido E; Yamamoto M; Sakamoto N
Am J Gastroenterol; 1989 Oct; 84(10):1250-4. PubMed ID: 2679047
[TBL] [Abstract][Full Text] [Related]
3. [The detection of serum hepatitis B virus Pre-S1 antigen and its relationship with HBeAg/anti-HBe and HBV DNA by polymerase chain reaction].
Xu B; Yao G
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):117-20. PubMed ID: 15619813
[TBL] [Abstract][Full Text] [Related]
4. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.
Theilmann L; Goeser T
Hepatogastroenterology; 1991 Feb; 38(1):10-3. PubMed ID: 1709133
[TBL] [Abstract][Full Text] [Related]
5. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
[TBL] [Abstract][Full Text] [Related]
6. A study of the binding ability of pre-S1 and S2 proteins of hepatitis B virus to human serum albumin.
Hu KQ; Yu ZQ; Li FH; Hao LJ
Hepatogastroenterology; 1990 Jun; 37(3):338-41. PubMed ID: 2373467
[TBL] [Abstract][Full Text] [Related]
7. Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle.
Poisson F; Severac A; Hourioux C; Goudeau A; Roingeard P
Virology; 1997 Feb; 228(1):115-20. PubMed ID: 9024817
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic expression of pre-S proteins of hepatitis B virus and its possible relation to liver cell necrosis.
Hu KQ; Hao LJ; Zhang YY; Wang YK
Am J Gastroenterol; 1989 Dec; 84(12):1538-42. PubMed ID: 2596456
[TBL] [Abstract][Full Text] [Related]
9. [The contrast study of Pre-S1 protein, HBV-DNA and HBeAg in diagnosing viral replication in patients with chronic hepatitis B].
Li Q; Sun GZ; Wei YX; Min YY; Cong YL; Ou XJ; Wang BE
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):134-6. PubMed ID: 15059293
[TBL] [Abstract][Full Text] [Related]
10. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
[TBL] [Abstract][Full Text] [Related]
11. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
[TBL] [Abstract][Full Text] [Related]
13. [Study on intrauterine infection of hepatitis B virus in pregnant women with hepatitis B surface antigen and hepatitis B e antigen negative].
Gui QD; Yue YF; Li SH; Zhang F
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):99-102. PubMed ID: 15840288
[TBL] [Abstract][Full Text] [Related]
14. [Determination of hepatitis B virus pre-S 2 antigen by reversed passive hemagglutination and its clinical significance].
Nakamura S; Iwatani Y; Sakai H; Katayama Y; Matsuyama T
Rinsho Byori; 1990 Aug; 38(8):895-900. PubMed ID: 2232250
[TBL] [Abstract][Full Text] [Related]
15. Analysis of hepatitis B virus in the cerumen and otorrhea of chronic HBV-infected patients: is there a hepatitis B virus infectivity?
Goh EK; Son BH; Kong SK; Chon KM; Cho KS
Otol Neurotol; 2008 Oct; 29(7):929-32. PubMed ID: 18665006
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
17. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.
Hsu CW; Yeh CT; Chang ML; Liaw YF
Gastroenterology; 2007 Feb; 132(2):543-50. PubMed ID: 17258721
[TBL] [Abstract][Full Text] [Related]
18. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
Romanò L; Biffi R; Bianchi S; Zanetti A
Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
[No Abstract] [Full Text] [Related]
19. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
20. [Application of serum hepatitis B virus large surface protein determination in lamivudine anti-viral therapy for patients with hepatitis B].
Li GY; Sheng JL; Huang HJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):133-5. PubMed ID: 18574538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
